Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$LAHO GSCG GLOBAL EXCELLENT!
https://www.forbes.com/sites/stevensalzberg/2014/05/05/stem-cells-may-repair-irreversible-heart-damage/#4a1b7ce46033
1 Cancer $1 Trillion
2 Alzheimer's disease $700B
3 Ophthalmologic therapies $343b
4 Tourism $179B
5 Organ repair $60B
6 3D printers $30B
7 Stem Bank $17.3B
8 Knee replacement?
9 ?
10 ?
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=151125240
$LAHO GSCG FUTURE OF MEDICINE TRILLION$$ REPRESENTING 46% MARKET GROWTH IN THERAPY REGENERATION, 3D PRINTING, COSMETIC, MEDICAL DEVICES, PROVIDER CONSULTATION. BOFA ESTIMATES $600 BILLION TARGET, USDHHS CONSERVATIVE ESTIMATE $500 billion AND IMPRESSIVE 7300% VENTURE CAPITAL INVESTMENT GROWTH. GOLDMAN SACH'S, BILLIONAIRES PURING MONEY INTO STEM CELLS. GSCG.. EACH DIVISION OF GSCG COULD RUN TO PENNIES..COMBINED?
$LAHO We were discussing past filing.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=151350310
SEC company search.
https://www.sec.gov/cgi-bin/browse-edgar?company=lans+holding&match=&CIK=&filenum=&State=&Country=&SIC=&owner=exclude&Find=Find+Companies&action=getcompany
$LAHO Filed with SEC and I read it, available for the public.
TO Profits$$$$
$LAHO An audit engagement is an arrangement that an auditor has with a client to perform an audit of the client's accounting records and financial
https://www.accountingtools.com/articles/2017/9/4/audit-engagement
Past Engagement Partner.
Appendix C — Matters Included in the Audit Engagement Letter
Summary Table of Contents+
C1. The auditor should include the following matters in the engagement letter.1/ The auditor's description of these matters will vary depending on whether the auditor is engaged in a financial statement audit or in an audit of internal control over financial reporting that is integrated with an audit of financial statements ("integrated audit").
The objective of the audit is:
Integrated audit: The expression of an opinion on both the effectiveness of internal control over financial reporting and the financial statements.
Audit of financial statements: The expression of an opinion on the financial statements.
https://pcaobus.org/Standards/Archived/PreReorgStandards/Pages/Auditing_Standard_16_Appendix_C.aspx
1 Cancer $1 Trillion
2 Alzheimer's disease $700B
3 Ophthalmologic therapies $343b
4 Tourism $179B
5 Organ repair $60B
6 3D printers $30B
7 Stem Bank $17.3B
8 Knee replacement?
9 Block Chain $1 Trillion
10 ?
We are beyond the first meeting.."performing, continues, finish"! Dave and Benito will make much money of completing the merger. Facts work..Multi trillion dollar market, folks with shares will profit$$$$.
$LAHO GSCG FUTURE OF MEDICINE$$$$$$$$$
$LAHO..On July 24, 2019, the Company dismissed GBH CPAs, PC (the “Former Accountant”) as the Company’s independent registered public accounting firm and on July 24, 2019, the Company engaged Fruci & Associates II, PLLC (the “New Accountant”) as the Company’s independent registered public accounting firm. The engagement of the New Accountant was approved by the Company’s Board of Directors.
The Former Accountant’s audit reports on the financial statements of the Company for the fiscal years ended November 30, 2016 and 2015 contained no adverse opinion or disclaimer of opinion, nor were they qualified or modified as to uncertainty, audit scope or accounting principles, except that the audit reports on the financial statements of the Company for the fiscal years ended November 30, 2016 and 2015 contained an uncertainty about the Company’s ability to continue as a going concern
..Other than as disclosed above, there were no reportable events during the fiscal years ended November 30, 2016 and 2015, and through the interim period ended July 24, 2019.
https://www.sec.gov/Archives/edgar/data/1422059/000166357719000317/mainbody.htm
Finra Top 100 issues LAHO NS?
https://otce.finra.org/otce/marketStatistics/top100Issues
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=151337694
Given the uncomplicated audit, and PR of LAHO & GSCGI looks good, and NS need this done pronto!
$LAHO Pay me now Pay me Later, future of medicine$$$
$LAHO (GSCG), a multi-disciplinary community of scientists and physicians collaborating to treat diseases and lessen human suffering through science, technology, and regenerative medicine, announced its participation in a new clinical trial in Miami.
https://www.printfriendly.com/p/g/s4G9DW
TAGGED UNDER:
GLOBAL AND LAHO, GLOBAL STEM CELLS GROUP, GLOBAL STEM CELLS GROUP NETWORK, GOOD MANUFACTURING PRACTICE, ISSCA, LAHO, LANS HOLDINGS
http://www.stemcellsgroup.com/lans-holdings-extension-to-complete-acquisition-of-gscg/
https://www.nasdaq.com/market-activity/ipos/overview?dealId=1048506-87910
$LAHO CLINICAL TRIALS, ADIMARKET, STEMDATA, BLOCKCHAIN, TWO TRILLION DOLLAR MARKETS COMBINED JUST A MATTER OF PATIENCE & PATIENTS$$$
$LAHO Completion will be on the SEC site and fins on the Auditor website.
https://www.sec.gov/edgar/searchedgar/companysearch.html
Auditor acknowledged they are in process noted in Lan's PR.
$LAHO GSCG FUTURE OF MEDICINE.
$LAHO ..Lans Holdings, Inc. is in the business of providing secure payment and communication solutions. The Company’s aim is to make it easier for sellers to start selling, and buyers to buy with confidence The Company intends that its solutions will be used to enable businesses to process payments more efficiently whether online or in a retail store front. The Company intends to offer white label solutions for payment service providers to enable business to consumer and business to business payments through physical POS, mobile devices, online and software integrations. The Company also intends to provide business processing outsourcing through its Fractional I.T. Services, and complaint ready hosted solutions through its Infrastructure on Demand..
https://www.sec.gov/Archives/edgar/data/1422059/000166357717000352/mainbody.htm
Fintech: paysperity
Short term for Financial Technology, describes a business that aims at providing financial services by making use of software and modern technology.
Biotech: Stem Cell Data
At its simplest, biotechnology is technology based on biology - biotechnology harnesses cellular and biomolecular processes to develop technologies and products that help improve our lives and the health of humans and our planet.
Auditor
Fruci & Associates
http://www.lans.holdings/
$GSCG The future of Medicine, each sector worth Billions, printers, cosmetic, therapy, marketing, tourism, medical devices. Billions of dollars from big pharm will find the route to regenerative care. Best to measure against the market as seen fit$$$
$LAHO GSCG anytime my friend. Don't forget the other clinical trial.
http://stemcellcenter.net/programs/
https://www.marketwatch.com/press-release/global-stem-cell-therapy-market-insight-business-evaluation-dimension-industry-grow-at-cagr-of-3652-trends-and-forecasts-2018-2023-2019-03-06
Another 2nd Clinical trial for GSCG
Pending Institutional Review Board (IRB) approval, Global Stem Cells Group, Inc. has announced plans to conduct a multi-centre, placebo controlled clinical trial to measure the safety and effectiveness of the intra-articular application of freshly isolated bone marrow stem cells for the treatment of osteoarthritis.
https://biovaultfamily.com/health-hub/musculoskeletal-conditions/global-stem-cells-group-plans-bone-marrow-clinical-trials-for-knee-osteoarthritis/
https://www.prunderground.com/global-stem-cells-group-takes-part-in-clinical-trial/00150836/
Prior trials.
https://www.prnewswire.com/news-releases/bioheart-announces-cell-therapies-program-in-latin-america-for-congestive-heart-failure-and-peripheral-arterial-disease-patients-88949077.html
Global Stem Cells Group, Inc. And Bioheart, Inc. Launch Clinical Trial For COPD Stem Cell Therapies
https://www.biospace.com/article/releases/-b-global-stem-cells-group-inc-b-and-bioheart-inc-launch-clinical-trial-for-copd-stem-cell-therapies-/
1 Cancer $1 Trillion
2 Alzheimer's disease $700B
3 Ophthalmologic therapies $343b
4 Tourism $179B
5 Organ repair $60B
6 3D printers $30B
7 Stem Bank $17.3B
8 Knee replacement?
9 ?
10 ?
$GSCG The future of Medicine, each sector worth Billions, printers, cosmetic, therapy, marketing, tourism, medical devices. Billions of dollars from big pharm will find the route to regenerative care. Best to measure against the market as seen fit$$$
$LAHO SUPER on schedule, updated August, GSCG was selected out of 20 in USA.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=151125240
$LAHO GSCG..REPRESENTING 46% MARKET GROWTH IN THERAPY REGENERATION, 3D PRINTING, COSMETIC, MEDICAL DEVICES, PROVIDER CONSULTATION. BOFA ESTIMATES $600 BILLION TARGET, USDHHS CONSERVATIVE ESTIMATE $500 billion AND IMPRESSIVE 7300% VENTURE CAPITAL INVESTMENT GROWTH. GOLDMAN SACH'S, BILLIONAIRES PURING MONEY INTO STEM CELLS. GSCG.
$LAHO How Sep not published ahhahah, smell of fear and fees!!!$$
Aug was Obv.. Revoked no greys OUCH$$$
Finra Top 100 issues LAHO NS?
https://otce.finra.org/otce/marketStatistics/top100Issues
$LAHO Pay me now Pay me Later$$$
$LAHO DD RM why Smart money and stem cells$$
Smart Money Is Piling Into Regenerative Medicine
The Goldman report discusses Samumed, a private RM company. With $300 million in funding,it’s valued at a staggering $12 billion Samumed’s drug platform aims to regenerate various tissues such as bone, cartilage, hair, and skin.
https://www.forbes.com/sites/patrickcox/2017/04/14/smart-money-is-piling-into-regenerative-medicine/#293ec5585b6c
Connections : Goldman Sachs Group Inc
New York Stem Cell Foundation, Inc.
https://www.marketscreener.com/GOLDMAN-SACHS-GROUP-INC-12831/company/
Hedgefund Mesoblast!
https://whalewisdom.com/stock/mblty
Mesoblast
Corporate Finance & Strategy
Mr Symonds was a Partner and Managing Director of Goldman Sachs Group Inc (2007-2009),
https://www.mesoblast.com/company/management-team
$LAHO TITANIC MARKET UPSIDE..NUMBER#1 GSCG
$LAHO Due Diligence no more cheapies..see Finra MM report?
Finra top 100 issues, LAHO 65% failed deliveries by NS?
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=151288664
Finra 32 pages of crooked firms-brokers-companions.
Disciplinary and Other FINRA Actions
Firm Fined, Individual Sanctioned
https://www.finra.org/sites/default/files/2019-09/Disciplinary_Actions_September_2019.pdf
https://www.finra.org/rules-guidance/oversight-enforcement/disciplinary-actions
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=150612914
The Commission is, of course, under no obligation to accept any settlement offer and may determine not to accept a simultaneous offer of settlement and waiver request on the basis of form alone.
https://www.sec.gov/news/public-statement/clayton-statement-regarding-offers-settlement
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=151255471
The SEC takes information alleging violations of the federal securities laws very seriously. If you have specific enforcement-related information, please submit the information at http://www.sec.gov/complaint/tipscomplaint.shtml
https://www.sec.gov/investor/pubs/regsho.htm
Failure through Aug-19
https://www.sec.gov/data/foiadocsfailsdatahtm
Finra SV view by date!
Date|Symbol|ShortVolume|ShortExemptVolume|TotalVolume|Market
20190905|LAHO|80988956|0|127916268|O
http://regsho.finra.org/FORFshvol20190905.txt
http://regsho.finra.org/regsho-Index.html
https://www.otcshortreport.com/company/LAHO
65% NS?? 32 pages remarkable!
$LAHO GSCG future of medicine$$
$LAHO correct not a scam, auditors confirmed & Global market research!
$LAHO Auditor & GSCG all about stem cells, Goldman Obv..
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=151125240
..engaged Fruci & Associates as its auditors as it moves forward to complete its audits and reviews of its financials to bring the company back to current status.
https://www.otcmarkets.com/stock/LAHO/news/story?e&id=1404069
http://www.lans.holdings
Connections : Goldman Sachs Group Inc
New York Stem Cell Foundation, Inc.
https://www.marketscreener.com/GOLDMAN-SACHS-GROUP-INC-12831/company/
Mesoblast
Corporate Finance & Strategy
Mr Symonds was a Partner and Managing Director of Goldman Sachs Group Inc (2007-2009),
https://www.mesoblast.com/company/management-team
1 Cancer $1 Trillion
2 Alzheimer's disease $700B
3 Ophthalmologic therapies $343b
4 Tourism $179B
5 Organ repair $60B
6 3D printers $30B
7 Stem Bank $17.3B
8 Knee replacement?
9 ? Biggest RM in OTC Historic.
10 ? My money is safe$$$$
$GSCG The future of Medicine, each sector worth Billions, printers, cosmetic, therapy, marketing, tourism, medical devices. Billions of dollars from big pharm will find the route to regenerative care. Best to measure against the market as seen fit$$$
$LAHO Auditor Fruci Audits Therapeutic Solutions,..Goldman Degenerative IPO Sep.
Form AP Filing Date
May 9, 2019
Financial Statement Year
2018
Engagement Partner
Kemper Leigh Rojas
Firm
Fruci & Associates II, PLLC
https://www.nasdaq.com/market-activity/ipos/overview?dealId=763041-56846
Degenerative disease biotech Frequency Therapeutics sets terms for $101 million IPO
..raise $101 million by offering 6.7 million shares at a price range of $14 to $16. At the midpoint of the proposed range, Frequency Therapeutics would command a fully diluted market value of $526 million.
Frequency Therapeutics was founded in 2014 and plans to list on the Nasdaq under the symbol FREQ. J.P. Morgan, Goldman Sachs, and Cowen are the joint bookrunners on the deal. It is expected to price during the week of September 30, 2019.
https://www.nasdaq.com/articles/degenerative-disease-biotech-frequency-therapeutics-sets-terms-for-%24101-million-ipo-2019
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=151125240
$LAHO Regenerative Care Trillion dollar market, Goldman$$
$LIBE Fails-to-Deliver Data SEC!
https://www.sec.gov/data/foiadocsfailsdatahtm
https://www.sec.gov/divisions/marketreg/mrfaqregsho1204.htm
..Rule 204 – Close-out Requirement. Rule 204 requires brokers and dealers that are participants of a registered clearing agency to take action to close out failure to deliver positions.
..If a firm that clears and settles trades has a failure to deliver that is not closed out by the beginning of regular trading hours on T+4 or T+6, as applicable, the firm has violated Rule 204 and the firm, and any broker-dealer from which it receives trades for clearance and settlement, is subject to the pre-borrow requirement for that security.
..Selling stock short and failing to deliver shares at the time of settlement with the purpose of driving down the security’s price. This manipulative activity, in general, would violate various securities laws, including Rule 10b-5 under the Exchange Act.
..Rule 204 provides an extended period of time to close out certain failures to deliver. Specifically, if a failure to deliver position results from the sale of a security that a person is deemed to own and that such person intends to deliver as soon as all restrictions on delivery have been removed, the firm has up to 35 calendar days following the trade date to close out the failure to deliver position by purchasing securities of like kind and quantity.
..The SEC takes information alleging violations of the federal securities laws very seriously. If you have specific enforcement-related information, please submit the information at www.sec.gov/complaint/tipscomplaint.shtml
https://www.sec.gov/investor/pubs/regsho.htm
Sec Office of the Whistleblower
100 F Street NE
Mail Stop 5631
Washington, DC 20549
Fax: (703) 813-9322
..The SEC treats all tips, complaints and referrals as confidential and nonpublic, and does not disclose such information to third parties, except in limited circumstances authorized by statute, rule, or other provisions of law.
https://www.sec.gov/whistleblower/submit-a-tip
The uncovered “naked” short positions that Respondents established were a key component of their complex trading strategy. From at least July 2010 through February 2012, Respondents established uncovered “naked” short positions in the securities of over 20 companies without taking any steps to deliver the securities and thus avoiding the costs associated with these obligations.
3. Respondents sold approximately $800 million worth of call options and purchased at least $1.2 billion worth of common stock in over 20 issuers.
https://www.sec.gov/litigation/admin/2014/33-9522.pdf
Where Naked Shorts Go to Die
Reverse mergers and reverse splits typically result in a change in the CUSIP, the nine-digit identification symbol assigned to a public stock.
Once that CUSIP changes, the naked shorter has no apparent way to close out the naked short position. No stock under the old CUSIP number exists anymore; it all automatically converts to the new CUSIP.
Those trades can sit in the Obligation Warehouse forever, in theory. But the “aged fails” — essentially orphaned naked short transactions — remain on the naked shorter’s balance sheet as a liability to be paid later.
By DiIorio’s reckoning, then, the cycle of naked shorting and reverse splits would inevitably result in an ever-increasing number of aged fails. And if that was happening, and those liabilities grew bigger and bigger, then federal regulators could see the outlines of the scheme on any financial statement.
DiIorio believed Knight accounted for its aged fails in the “sold not yet purchased” liability on its balance sheet. That’s supposed to be an inventory of stocks for use in future market making, which goes up and down as orders are filled. But DiIorio says it was a hiding place for a billowing structural liability.
Part4
Calling the Sec
https://theintercept.com/2016/09/24/naked-shorts-cant-stay-naked-forever/
Failure through Aug-19
https://www.sec.gov/data/foiadocsfailsdatahtm
Finra 32 pages of crooked firms-brokers-companions.
Disciplinary and Other FINRA Actions
Firm Fined, Individual Sanctioned
https://www.finra.org/sites/default/files/2019-09/Disciplinary_Actions_September_2019.pdf
https://www.finra.org/rules-guidance/oversight-enforcement/disciplinary-actions
FINRA President and CEO, Robert Cook, framed FINRA’s mission for 2018 as follows: to protect investors and promote market integrity in a manner that facilitates vibrant capital markets. In 2018, FINRA’s priorities will include a focus on six specific areas:
Fraud;
High-risk Firms and Brokers;
Operational and Financial Risks;
Sales Practice Risks;
Market Integrity; and
New Rules.
https://www.corporatecomplianceinsights.com/finras-top-6-concerns-in-2018/
$LIBE Pay now pay me later$$$
$LAHO Agreed, Dave and Benito are professionals.
One of the predictions he listed was that by 2030, "humanity will have achieved Longevity Escape Velocity for the wealthiest."
https://www.dw.com/en/what-if-billionaires-could-live-forever/a-42840013
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=150871471
Brings leadership in stem cell research, patient applications, and training to you through our state-of-the-art global network of companies. Our mission is to enable physicians to make the benefits of stem cell medicine a reality for patients around the world.
http://www.stemcellsgroup.com/
$LAHO GSCG FUTURE OF MEDICINE, SUPPORTED BY WEALTHY$$
$LAHO GLOBAL STEM CELLS OFFICE $167k per year, Top Location!!!
$23.95 /SF/Yr
6,982 SF
A Class “A” office building
Demographics Salary $95k
https://www.loopnet.com/Listing/14750-NW-77th-Ct-Miami-Lakes-FL/6530268/
US health..spending increased 5.8%..3.2 Trillion
https://www.prnewswire.com/news-releases/global-stem-cell-and-regenerative-medicine-market-demand-analysis--opportunity-report-2018-market-is-expected-to-garner-usd-14-74-billion-by-the-end-of-2024--300735187.html
BLOCKCHAIN $1 Trillion
1 Cancer $1 Trillion
2 Alzheimer's disease $700B
3 Ophthalmologic therapies $343b
4 Tourism $179B
5 Organ repair $60B
6 3D printers $30B
7 Stem Bank $17.3B
8 Knee replacement?
9 ?
10 ?
$LAHO GSCT TWO TRILLION DOLLAR MARKET, BLOCK CHAIN & STEM CELLS$$
$LAHO Office 4-5th floor $108K per year.
https://images1.loopnet.com/d2/0Kd_Jbdn4HMCCABX27MbBXChJU8ml_pylA-wEAAsTdI/document.pdf
https://www.loopnet.com/xNet/Looplink/TmplEngine/ListingProfilePage.aspx?LID=11174053&siteid=3349&LL=true
https://www.loopnet.com/Listing/777-Brickell-Ave-Miami-FL/11174053/
$LAHO GSCG future of medicine
$LAHO wheels already in motions, next is audit fins with form 10, followed form 211, Patience and patients, my friend$$
The Commission is, of course, under no obligation to accept any settlement offer and may determine not to accept a simultaneous offer of settlement and waiver request on the basis of form alone.
https://www.sec.gov/news/public-statement/clayton-statement-regarding-offers-settlement
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=151255471
..Shareholders of both companies surrender their stock shares and receive in return shares in the new company based on the value of the shares they originally owned.
https://www.finra.org/investors/insights/how-companies-use-their-cash-mergers-and-acquisitions
in discussions with a market maker who has expressed preliminary interest to work with the Company on its Form 211 filing to reinstate trading of the Company’s shares on the OTC Pinks.
http://www.globenewswire.com/news-release/2019/09/20/1918533/0/en/Lans-Holdings-Plans-to-File-Form-10-with-the-SEC-and-Target-Reinstatement-of-its-Symbol-on-OTC-Pinks.html
For an uncomplicated reporting company audited by a “Big Five” firm,1
..1 An example that we identified at random was a reporting company under section 12(g) of the Exchange Act that manufactures high-technology equipment for medical, scientific, and research applications. Its stock is quoted for less than $0.50 per share..
Sam Scott Miller, Esq.
Orrick, Herrington & Sutcliffe LLP
https://www.finra.org/sites/default/files/notice_comment_file_ref/Comments%20to%20211%20Repository%20%28FINAL%29_0.pdf
$LAHO GSCG Future of medicine, stem cells, big pharma transforming their operations towards regenerative care GSCG audit & LEGAL team, a perfect match-scenario in Finra’s rule testing methodology “uncomplicated” or fast track.. future of medicine$$$ .
$LAHO on Finra top 100 issues, are they part of the 65% failed deliveries by NS?
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=151288664
Awards ceremony for Finra 32 pages of crooked firms-brokers-companions.
Disciplinary and Other FINRA Actions
Firm Fined, Individual Sanctioned
https://www.finra.org/sites/default/files/2019-09/Disciplinary_Actions_September_2019.pdf
https://www.finra.org/rules-guidance/oversight-enforcement/disciplinary-actions
Alpine once again doing a two for me one for you.
FINRA President and CEO, Robert Cook, framed FINRA’s mission for 2018 as follows: to protect investors and promote market integrity in a manner that facilitates vibrant capital markets. In 2018, FINRA’s priorities will include a focus on six specific areas:
Fraud;
High-risk Firms and Brokers;
Operational and Financial Risks;
Sales Practice Risks;
Market Integrity; and
New Rules.
https://www.corporatecomplianceinsights.com/finras-top-6-concerns-in-2018/
2018-2019 Ceo Finra awards MM-firms top two spots, 32 pages incredible!
$LAHO GSCG future of medicine$$
$LIBE bought on the dip, time to move up.
$LIBE CLOSE .003 TODAY?
.. Overview of Business of Ngen
Ngen is engaged in the business of automotive technology, biomedical technology, and glasses free 3D display technology. Through its wholly-owned subsidiary Ngen Technologies Korea Ltd (“Ngen Korea”), Ngen currently designs, develops, and sells technology that enables glasses free 3D display for use in smartphones, televisions, and tablets, which we refer to collectively as its “Glasses Free 3D Technologies.” Ngen also designs, develops, and sells automotive technologies, and has developed a silencer/muffler system that enables greater fuel efficiency for automobiles. Through its holdings in Emotek Corporation, a Taiwan based company (“Emotek”) that is jointly-owned with Egismos Technologies Corporation, a manufacturer of laser-based light sources (“Egismos Technologies”), Ngen is also seeking to introduce innovative biomedical products, including a tumor detection scanner using laser and Micro-Electro-Mechanical Systems (MEMS).
https://ih.advfn.com/stock-market/USOTC/liberated-energy-inc-LIBE/stock-news/80738729/current-report-filing-8-k#EX10-1_HTM
$LIBE Medical, Automotive, Value$$$
$LAHO 'Go to Zero' Isn't Great for Short Sellers
It's hard to bet on disaster, because that's when bets tend not to get paid off.
.. If a stock "goes to zero" by going from $20 to 2 cents, or if it "goes to zero" through a formal bankruptcy process, then that is a pretty unequivocal win for the short seller. But some other paths to zero are ... actually ... bad?
Gates says he is stuck short China-Biotics, for instance, a stock that was halted in November 2013 when the Securities and Exchange Commission revoked its registration. The shares were delisted, and the company shut down. Gates showed us a January 2018 letter that he says he sent to the stock market record keepers at The Depository Trust Co., in which he laments that a TFS mutual fund has paid hundreds of thousands of dollars in stock-loan fees on China-Biotics and remained subject to the $2.50 a share margin required by Financial Industry Regulatory Authority rules. A handful of other short positions have him in the same predicament.
Gates is Rich Gates of TFS Capital, who "has joined an industry committee that the Securities Industry and Financial Markets Association calls the Worthless Securities Working Group." He shorted some stocks that he thought were frauds, and the SEC agreed that they were frauds and halted them, and then ... things got worse for him. The shares were worthless, but they didn't trade at zero or $0.01 or whatever: They didn't trade at all, so he couldn't buy them back to deliver to his stock lenders. Here is his letter to DTCC, which notes:
DTCC maintains securities in its records indefinitely that are worthless and illiquid; these securities have not been "taken down" by DTCC despite the fact that they have been deregistered by the SEC, delisted by the exchanges, have no existing business location, operations, management or employees and their registration is not in good standing in their state of incorporation.
Gates blames the brokers who loaned him the stock for this situation (and calls it "a glaring conflict of interest" for them), but that is not the whole story. "Gates’ prime brokers aren’t necessarily pocketing stock-loan fees—they may have to pass them on to other firms that supplied the borrowed shares," notes Bill Alpert at Barron's. The only way to (legally) short stock is to borrow it from someone who owns it, and your stock borrow fee makes its way back to that owner-lender (with brokers taking a cut). The actual conflict is that whoever was long China-Biotics stock is still making money from it in its limbo; if the stock borrow fees are high enough and the limbo goes on long enough, they might make more from the stock borrow fees than they would have if the company had been successful. The incentives in stock lending are always a little weird -- you are making a little extra money on the stock you own by helping someone bet against that stock -- but here they are downright perverse.
https://www.google.com/amp/s/www.bloomberg.com/amp/opinion/articles/2018-04-11/-go-to-zero-isn-t-great-for-short-sellers
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=151279056
$LAHO GSCG Future of Medicine$$$
$LAHO thanks, CUSIP also changes with merger and name change combination.
DTC also takes note of the change. Failure to deliver subjects brokers to legal consequences.
..Rule 204 – Close-out Requirement. Rule 204 requires brokers and dealers that are participants of a registered clearing agency to take action to close out failure to deliver positions.
..If a firm that clears and settles trades has a failure to deliver that is not closed out by the beginning of regular trading hours on T+4 or T+6, as applicable, the firm has violated Rule 204 and the firm, and any broker-dealer from which it receives trades for clearance and settlement, is subject to the pre-borrow requirement for that security.
..Selling stock short and failing to deliver shares at the time of settlement with the purpose of driving down the security’s price. This manipulative activity, in general, would violate various securities laws, including Rule 10b-5 under the Exchange Act.
..Rule 204 provides an extended period of time to close out certain failures to deliver. Specifically, if a failure to deliver position results from the sale of a security that a person is deemed to own and that such person intends to deliver as soon as all restrictions on delivery have been removed, the firm has up to 35 calendar days following the trade date to close out the failure to deliver position by purchasing securities of like kind and quantity.
..The SEC takes information alleging violations of the federal securities laws very seriously. If you have specific enforcement-related information, please submit the information at http://www.sec.gov/complaint/tipscomplaint.shtml
https://www.sec.gov/investor/pubs/regsho.htm
Failure through Aug-19
https://www.sec.gov/data/foiadocsfailsdatahtm
Finra SV view by date!
Date|Symbol|ShortVolume|ShortExemptVolume|TotalVolume|Market
20190905|LAHO|80988956|0|127916268|O
http://regsho.finra.org/FORFshvol20190905.txt
http://regsho.finra.org/regsho-Index.html
https://www.otcshortreport.com/company/LAHO
$LAHO GSCG future of medicine
$LAHO Sec settled with LAHO when it was under no obligation, lets wait for PR on investigation of MM and parties.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=151278596
The Commission is, of course, under no obligation to accept any settlement offer and may determine not to accept a simultaneous offer of settlement and waiver request on the basis of form alone.
https://www.sec.gov/news/public-statement/clayton-statement-regarding-offers-settlement
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=151255471
..Shareholders of both companies surrender their stock shares and receive in return shares in the new company based on the value of the shares they originally owned.
https://www.finra.org/investors/insights/how-companies-use-their-cash-mergers-and-acquisitions
in discussions with a market maker who has expressed preliminary interest to work with the Company on its Form 211 filing to reinstate trading of the Company’s shares on the OTC Pinks.
http://www.globenewswire.com/news-release/2019/09/20/1918533/0/en/Lans-Holdings-Plans-to-File-Form-10-with-the-SEC-and-Target-Reinstatement-of-its-Symbol-on-OTC-Pinks.html
For an uncomplicated reporting company audited by a “Big Five” firm,1
..1 An example that we identified at random was a reporting company under section 12(g) of the Exchange Act that manufactures high-technology equipment for medical, scientific, and research applications. Its stock is quoted for less than $0.50 per share..
Sam Scott Miller, Esq.
Orrick, Herrington & Sutcliffe LLP
https://www.finra.org/sites/default/files/notice_comment_file_ref/Comments%20to%20211%20Repository%20%28FINAL%29_0.pdf
Benito just super liked a comment on his FB regarding the 180 day extension, wheels are in motion, folks that own are in good health.
$LAHO GSCG embrace stemcells, big pharma transforming their operations towards regenerative care GSCG audit & LEGAL team, a perfect match-scenario in Finra’s rule testing methodology “uncomplicated” or fast track.. future of medicine$$$ .
$LAHO insignificant blog, makes for good entertainment.
Couldnt be further from market research!
$LAHO three months after the fact. Sad for shorts, i’d lose sleep, Sec fines, possible investigation, wonder when MM+manipulator parties will be served by sheriff, serious matter.
Sec whistle blowers!
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=151279056
Someone’s career permanent halt being financial industry.
Fine lesson & poor judgement for naked shorts & manipulators..Yikes!
$LAHO Would not be measurable or fair to this merger or its future.
$LAHO 2017 is over two years ago and notes were exchanged pref shares given the volume likely done with.
More importantly GSCG is worth so much any debt is not worth mentioning.
$LAHO the real deal$$$
$LAHO..Lans Holdings has no debt.
Lans Holdings currently has no debt however we can't compare to 5 years ago as we have no data for that period.
Lans Holdings has no debt, it does not need to be covered by operating cash flow.
Lans Holdings has no debt, therefore coverage of interest payments is not a concern.
SIMILAR COMPANIES
Wells Fargo
NYSE:WFC
Global Payments
NYSE:GPN
Worldpay
1 Year Return
4500.0%
https://simplywall.st/stocks/us/software/otc-laho/lans-holdings
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=151125240
$LAHO GSCG Blockchain $ Stem Cells two trillion dollar market, will be back to skyrocket$$$
$LAHO Where Naked Shorts Go to Die
DiIorio also spotted a significant, seemingly toxic byproduct of this sort of activity.
Reverse mergers and reverse splits typically result in a change in the CUSIP, the nine-digit identification symbol assigned to a public stock.
Once that CUSIP changes, the naked shorter has no apparent way to close out the naked short position. No stock under the old CUSIP number exists anymore; it all automatically converts to the new CUSIP.
Those trades can sit in the Obligation Warehouse forever, in theory. But the “aged fails” — essentially orphaned naked short transactions — remain on the naked shorter’s balance sheet as a liability to be paid later.
By DiIorio’s reckoning, then, the cycle of naked shorting and reverse splits would inevitably result in an ever-increasing number of aged fails. And if that was happening, and those liabilities grew bigger and bigger, then federal regulators could see the outlines of the scheme on any financial statement.
DiIorio believed Knight accounted for its aged fails in the “sold not yet purchased” liability on its balance sheet. That’s supposed to be an inventory of stocks for use in future market making, which goes up and down as orders are filled. But DiIorio says it was a hiding place for a billowing structural liability.
Part4
Calling the Sec
https://theintercept.com/2016/09/24/naked-shorts-cant-stay-naked-forever/
The uncovered “naked” short positions that Respondents established were a key component of their complex trading strategy. From at least July 2010 through February 2012, Respondents established uncovered “naked” short positions in the securities of over 20 companies without taking any steps to deliver the securities and thus avoiding the costs associated with these obligations.
3. Respondents sold approximately $800 million worth of call options and purchased at least $1.2 billion worth of common stock in over 20 issuers.
https://www.sec.gov/litigation/admin/2014/33-9522.pdf
Sec Office of the Whistleblower
100 F Street NE
Mail Stop 5631
Washington, DC 20549
Fax: (703) 813-9322
..The SEC treats all tips, complaints and referrals as confidential and nonpublic, and does not disclose such information to third parties, except in limited circumstances authorized by statute, rule, or other provisions of law.
https://www.sec.gov/whistleblower/submit-a-tip
Both your transfer agent and IR firm should be able to advise you on the effectiveness of combating naked shorts by changing CUSIP numbers, reverse mergers, and/or reverse splits. Although the long-term effectiveness of these strategies is questionable, it may be useful as part of a larger strategy to deter naked shorting. After changing your company's CUSIP number, for instance, all existing stock certificates must be exchanged for new ones. All issued and outstanding certificates from old shares will no longer represent an interest in the company until exchanged."
http://www.hawkassociates.com/ir/white/shorts.cfm
Pay now pay me later.. including if RS or New CUSIP!!
$LAHO right and stem cells will evaporate and vanish!
Ahah
$LAHO smell of fear is everywhere questions is, what is more sleazy..the parties or MM..orchestrated abuse?
Pay me now pay me later$$$